000 | 01873 a2200517 4500 | ||
---|---|---|---|
005 | 20250513210607.0 | ||
264 | 0 | _c20000713 | |
008 | 200007s 0 0 eng d | ||
022 | _a0941-4355 | ||
024 | 7 |
_a10.1007/s005200050286 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarde, P | |
245 | 0 | 0 |
_aA phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. _h[electronic resource] |
260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cMay 2000 |
||
300 |
_a203-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucose Oxidase _xadministration & dosage |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xradiotherapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLactoperoxidase _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuramidase _xadministration & dosage |
650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aXerostomia _xdiagnosis |
700 | 1 | _aKroll, B | |
700 | 1 | _aO'Sullivan, B | |
700 | 1 | _aAslanidis, J | |
700 | 1 | _aTew-George, E | |
700 | 1 | _aWaldron, J | |
700 | 1 | _aMaxymiw, W | |
700 | 1 | _aLiu, F F | |
700 | 1 | _aPayne, D | |
700 | 1 | _aCummings, B | |
773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 8 _gno. 3 _gp. 203-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s005200050286 _zAvailable from publisher's website |
999 |
_c10742297 _d10742297 |